Pancreatic cancer

Medicine (United Kingdom)

Volumn 43, Issue 6, 2015, Pages 329-333

  Pai, Madhava ^a   Spalding, Duncan ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Palliative care; Pancreatic cancer; Radiation therapy; Surgery

Indexed keywords

ANALGESIC AGENT; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADVANCED CANCER; ARTICLE; BILIARY STENT; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; DISTAL PANCREATECTOMY; DUODENUM OBSTRUCTION; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; JAUNDICE; LAPAROSCOPIC PANCREATIC RESECTION; LAPAROSCOPY; LONG TERM SURVIVAL; PAIN; PALLIATIVE THERAPY; PANCREAS BIOPSY; PANCREAS CANCER; PANCREAS PAIN; PANCREAS RESECTION; PANCREATIC DUCT STENT; PANCREATICODUODENECTOMY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADICAL PANCREATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STOMACH OBSTRUCTION;

EID: 84942848613     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2015.03.001     Document Type: Review

References (20)

1. Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapywith fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 2010; 304: 1073e81.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71e96.
3. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004; 27: 1049e57.
4. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82: 111e5.
5. Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000; 11: 915e23.
6. Lowenfels AB, Maisonneuve P, DiMagno EP, et al. International Hereditary Pancreatitis Study Group. Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 1997; 89: 442e6.
7. Jacobs EJ, Chanock SJ, Fuchs CS, et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer 2010; 127: 1421e8.
8. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114e7.
9. Lermite E, Sommacale D, Piardi T, et al. Complications after pancreatic resection: diagnosis, prevention and management. Clin Res Hepatol Gastroenterol 2013; 37: 230e9.
10. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 7 consecutive resections without an operative mortality. Ann Surg 1990; 211: 447e58.
11. Pitt HA. Curative treatment for pancreatic neoplasms. Standard resection. Surg Clin North Am 1995; 75: 891e904.
12. Herter FP, Cooperman AM, Ahlborn TN, Antinori C. Surgical experience with pancreatic and periampullary cancer. Ann Surg 1982; 195: 274e81.
13. Satake K, Nishiwaki H, Yokomatsu H, et al. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 1992; 175: 259e65.
14. Leach SD, Lee JE, Charnsangavej C, et al. Survival following pancreaticoduodenectomy with resection of the superior mesentericportal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 1998; 85: 611e7.
15. Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg 2002; 6: 147e57.
16. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 1998; 227: 821e31.
17. Gudjonsson B. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 1995; 181: 483e503.
18. Speer AG, Cotton PB, Russell RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987; 2: 57e62.
19. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340: 1488e92.
20. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817e25.